I started with Lupron+Abiraterone + Docetaxel. As I mentioned before elevated liver enzymes caused MO to place me on an Abiraterone vacation after cycle 1 of Docetaxel. Docetaxel was reduced to 3/4 dosage.
Yesterday, I received my 3rd cycle of 3/4 dosage of Docetaxel, my 3 month injection of Lupron and monthly xGeva injection. But, I was told not to resume Abiraterone.
I started out following the Peace-1 trial; but my MO is prioritizing the Docetaxel treatment over the hormonal treatment. Although it hasn’t been communicated to me, I suspect that I resume Abiraterone until after the 6th Docetaxel cycle. What are the implications of this decision?
I understand that the Abiraterone inhibits the cancer’s ability to create its own testosterone. Does the Docetaxel accomplish the same thing? I’m guessing the answer is no, or the Peace1 trial would have given all participants a Abiraterone vacation otherwise.
My thought is to have my MO run labs and if my liver enzymes are within limits, I would like to resume Abiraterone. Then, a week before my next cycle, check my labs again, to make sure that resuming Abiraterone didn’t push the enzyme levels high enough to cause a delay in Docetaxel. Thoughts?
Again, my thoughts are based on the theory that all three treatments are essential to achieving the survivor objectives. Quite frankly, if I’m risking my life expectancy and giving up QOL, then, I want to re-think the entire treatment plan.